Sfoglia per RIVISTA
BLOOD CANCER JOURNAL
Collezione AO Cuneo

  

Items : 6

Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial. in Blood cancer journal / Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5.

2024
AO Cuneo
AOU Città della Salute di Torino

Iori AP; Bernasconi P; Corradini P; Russo D; Nagler A; Carella AM; Marotta G; Cerretti R; Rivela P; Terruzzi E; Saporiti G; Pane F; Patriarca F; Saccardi R; Musto P; Chiusolo P; Olivieri A; Milone G; Santarone S; Borghero C; Cavattoni IM; Busca A; Micò MC; Pavoni C; Grassi A; Cavallaro G; Castagna L; Mordini N; Oldani E; et alii...

Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients. in Blood cancer journal / Blood Cancer J. 2022 Jan 18;12(1):8. doi: 10.1038/s41408-022-00608-6.

2022
AOU Alessandria
AO Cuneo
AOU Novara

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Mahmoud AM; Gaidano V; Patriarca A; Ferrante D; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M;

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma. in Blood cancer journal / Blood Cancer J. 2021 Jan 7;11(1):8. doi: 10.1038/s41408-020-00394-z.

2021
AO Cuneo

Ansell SM; Paludo J; Cerhan JR; Inwards DJ; Ristow KM; King RL; Habermann TM; Wang Y; Tun AM; Castellino A; Witzig TE; Nowakowski GS;

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Larocca A; Corradini P; Monaco F; Boccadoro M; Ballanti S; Offidani M; De Paoli L; De Sabbata G; Aquino S; Paris L; Grasso M; Belotti A; Cellini C; Tacchetti P; Zambello R; Musolino C; Cea M; Bonello F; Rota-Scalabrini D; Patriarca F; Capra A; Petrucci MT; Ciccone G; Liberati AM; Pescosta N; Bringhen S; Falcone AP; Mina R;

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.

2020
ASL Asti
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Larocca A; Romano A; Sonneveld P; Ria R; Musto P; Liberati AM; Offidani M; Giuliani N; Marchetti M; Mosca-Siez ML; de Fabritiis P; Gobbi M; Ballanti S; Cellini C; Grasso M; Monaco F; Ronconi S; Pescosta N; Di Lullo G; Capra A; Belotti A; Petrucci MT; Boccadoro M; Zambello R; Mina R;

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients. in Blood cancer journal / Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

2016
AO Cuneo

De Stefano V; Vannucchi AM; Ruggeri M; Cervantes F; Alvarez-Larrán A; Iurlo A; Randi ML; Pieri L; Rossi E; Guglielmelli P; Betti S; Elli E; Finazzi MC; Finazzi G; Zetterberg E; Vianelli N; Gaidano G; Nichele I; Cattaneo D; Palova M; Ellis MH; Cacciola E; Tieghi A; Hernandez-Boluda JC; Pungolino E; Specchia G; Rapezzi D; Forcina A; Musolino C; et alii...